Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proof Of Concept Study of Orcinoside in the Treatment of Major Depressive Disorder(MDD): a Randomized, Double-Blind, Placebo-Paralleled,Dose-Finding, Multicenter Clinical Trial

NCT02191384 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.

NCT NCT02191384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02191384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proof Of Concept Study of Orcinoside in the Treatment of Major Depressive Disorder(MDD): a Randomized, Double-Blind, Placebo-Paralleled,Dose-Finding, Multicenter Clinical Trial
Lead sponsor
Shanghai Mental Health Center
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2014
Completion date
March 9, 2016
Enrollment
186 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd)